Dual Antiplatelet Therapy and Arteriovenous Malformations Increase 30-Day Readmission Rates for Patients Who Undergo Endoscopic Procedures for Gastrointestinal Bleeding

Key Points

• This research investigates the impact of dual antiplatelet therapy and arteriovenous malformations on 30-day readmission rates after endoscopic procedures for gastrointestinal bleeding.
• Analyzed inpatient endoscopy cases for gastrointestinal bleeding
• Assessed the use of dual antiplatelet therapy and presence of arteriovenous malformations
• Evaluated 30-day readmission outcomes
• DAPT and AVMs were independently linked to higher readmission rates
• Highlighting the need for enhanced discharge planning and follow-up strategies
• Identified high-risk populations that could benefit from targeted interventions

Abstract